The CDC recently released a study in JAMA that points to healthcare settings as the main site of C. diff acquisition for healthy people, with 82% of C diff. cases acquired in healthcare facilities. C.
Late last year, The Jewish Hospital-Mercy Health in Cincinnati received a first-place award in a multi-state competition for its efforts to reduce Clostridium difficile infections among inpatients.
Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure. Early testing facilitates prompt diagnosis and management, influencing ...
In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal ...
Clostridioides difficile/Clostridium difficile (C. diff) is a bacterial infection and is the most common cause of healthcare-associated diarrhea. C. diff has two distinct presentations, primary and ...
Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of health-care-associated ...
Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...
Bethesda, MD (Feb. 21, 2024) — In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...
Amid National C. Diff Awareness Month, Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C. Diff Education & Advocacy, explains the foundation's "See C. diff" ...